Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives
Fabiana Alves(Drugs for Neglected Diseases Initiative), Jorge Alvar(Real Academia Española), Susan Wells(Drugs for Neglected Diseases Initiative), Graeme Bilbe(Drugs for Neglected Diseases Initiative), Nathalie Strub‐Wourgaft(Drugs for Neglected Diseases Initiative), Monique Wasunna(Kenya AIDS Vaccine Initiative), Séverine Monnerat(Drugs for Neglected Diseases Initiative), Séverine Blesson(Drugs for Neglected Diseases Initiative), Bernard Pécoul(Drugs for Neglected Diseases Initiative), Byron Arana(Drugs for Neglected Diseases Initiative), Charles E. Mowbray(Drugs for Neglected Diseases Initiative), Vishal Goyal(Chandigarh University), Suman Rijal(Nepal Cancer Hospital and Research Center), Joelle Rode(Drugs for Neglected Diseases Initiative), Gina Muthoni Ouattara(Drugs for Neglected Diseases Initiative), Eduard E. Zijlstra(GGD Rotterdam-Rijnmond), Alexandra Solomos(Drugs for Neglected Diseases Initiative)
Cited by 218
Related Papers
Neuropathology in Mice Expressing Human α-Synuclein
|Journal of Neuroscience|2000|473
Mycetoma: a unique neglected tropical disease
|The Lancet Infectious Diseases|2015|343
Development of a Species-Specific PCR-Restriction Fragment Length Polymorphism Analysis Procedure for Identification of <i>Madurella mycetomatis</i>
|Journal of Clinical Microbiology|1999|112
The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis
|Transactions of the Royal Society of Tropical Medicine and Hygiene|2011|104
A New Model for Management of Mycetoma in the Sudan
|PLoS neglected tropical diseases|2014|96